Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | BLM | P54132 | 3/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | RGS12 | O14924 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL388561 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL18824897 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL3258 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL388563 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL8080341 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL3259 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL163443 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL163442 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL995910 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA | |
| Histidine SCHEMBL8316642 | 0.98 | SLC7A5 (0.47) | CYP3A4SLC7A5CYP1A2KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114354533-B | Meat enzymolysis pet food with antioxidant activity and preparation process thereof | 弘煋科技(北京)有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-114354533-A | Meat enzymolysis pet food with antioxidant activity and preparation process thereof | 弘煋科技(北京)有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-117110233-B | Meat enzymolysis pet food technology containing XN2 for measuring and controlling oxidation activity of release substances | 上海福贝宠物用品股份有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-117110233-A | Meat enzymolysis pet food technology containing XN2 for measuring and controlling oxidation activity of release substances | 弘煋科技(北京)有限公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20230145406-A1 | DIVALENT METAL-CONTAINING BIOMATERIALS AND METHODS OF USE | UNIVERSITY OF OREGON (US) | 2023-05-11 | — | — | US | disclosed |
| CN-114354533-B | Meat enzymolysis pet food with antioxidant activity and preparation process thereof | 弘煋科技(北京)有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-114354533-A | Meat enzymolysis pet food with antioxidant activity and preparation process thereof | 弘煋科技(北京)有限公司 | 2022-04-15 | — | — | CN | disclosed |
| US-20170204127-A1 | COORDINATION COMPLEXES, PHARMACEUTICAL SOLUTIONS COMPRISING COORDINATION COMPLEXES, AND METHODS OF TREATING PATIENTS | SYNTHONICS INC (US) | 2017-07-20 | — | — | US | disclosed |
| US-9624256-B2 | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients | SYNTHONICS, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-20140274936-A1 | COORDINATION COMPLEXES, PHARMACEUTICAL SOLUTIONS COMPRISING COORDINATION COMPLEXES, AND METHODS OF TREATING PATIENTS | SYNTHONICS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-8779175-B2 | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients | SYNTHONICS, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| EP-2579864-A1 | COORDINATION COMPLEXES, PHARMACEUTICAL SOLUTIONS COMPRISING COORDINATION COMPLEXES, AND METHODS OF TREATING PATIENTS | Synthonics, Inc. (US) | 2013-04-17 | — | — | EP | disclosed |
| WO-2011149757-A1 | COORDINATION COMPLEXES, PHARMACEUTICAL SOLUTIONS COMPRISING COORDINATION COMPLEXES, AND METHODS OF TREATING PATIENTS | SYNTHONICS, INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20100240601-A1 | Coordination Complexes, Pharmaceutical Solutions Comprising Coordination Complexes, and Methods of Treating Patients | SYNTHONICS, INC. | 2010-09-23 | — | — | US | disclosed |
| US-20090182044-A1 | NITRATE AMINO ACID CHELATES | ALBION INTERNATIONAL, INC. | 2009-07-16 | — | — | US | disclosed |
| WO-2009089493-A2 | NITRATE AMINO ACID CHELATES | ALBION INTERNATIONAL, INC. (US) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182044-A1 | NITRATE AMINO ACID CHELATES | NPPA, ARG1, MAX | CYP3A4 2484/4885SLC7A5 68/4885CYP1A2 1602/4885 |
| US-20170204127-A1 | COORDINATION COMPLEXES, PHARMACEUTICAL SOLUTIONS COMPRISING COORDINATION COMPLEXES, AND METHODS OF TREATING PATIENTS | PDE8A, MC2R, PKD1 | CYP3A4 1496/4885SLC7A5 1456/4885CYP1A2 3377/4885 |
| US-20100240601-A1 | Coordination Complexes, Pharmaceutical Solutions Comprising Coordination Complexes, and Methods of Treating Patients | PDE8A, MC2R, PKD1 | CYP3A4 1496/4885SLC7A5 1456/4885CYP1A2 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.